Skip to main content
OpenTrials

Clinical trial condition

KRAS p.G12C Mutant Advanced Solid Tumors

Explore clinical trials studying KRAS p.G12C Mutant Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

KRAS p.G12C Mutant Advanced Solid Tumors trial results

Completed

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)

NCT03600883

Conditions
KRAS p.G12C Mutant Advanced Solid Tumors
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California at SF San Francisco, California, United States
  • Sarcoma Oncology Research Center LLC Santa Monica, California, United States
View all 133 locations
View Trial Details